Nami Yamashita
Ariake, 1358550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: July 02, 2026
Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.
Journal: Journal of medical Internet research
Published: April 09, 2026
Perceived usefulness of online videos for hereditary breast cancer communication in Japan: Patient and provider perspectives.
Journal: Public health in practice (Oxford, England)
Published: March 03, 2026
ASO Visual Abstract: Feasibility of Omitting Axillary Dissection After Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Single-Center Retrospective Study.
Journal: Annals of surgical oncology
Published: February 06, 2026
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.
Journal: Breast disease
Published: December 05, 2025
Feasibility of Omitting Axillary Dissection after Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Single-Center Retrospective Study.
Journal: Annals of surgical oncology
Published: August 26, 2025
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 18, 2024
Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer.
Journal: Breast cancer research : BCR
Published: December 17, 2024
Assessing the quality of Japanese online breast cancer treatment information using large language models: a comparison of ChatGPT, Claude, and expert evaluations.
Journal: Breast cancer (Tokyo, Japan)
Published: November 20, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Journal: Breast cancer (Tokyo, Japan)
Published: September 17, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Journal: Cancer research communications
Published: January 09, 2024
Last Updated: 09/26/2026